Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Pulmonology

Background:

• Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality.
• Accurate etiological diagnosis of CAP is crucial for targeted therapy but often difficult.
• Different pathogens may present with overlapping or distinct clinical and laboratory features.

Purpose of the Study:

• To compare the clinical and laboratory features of community-acquired pneumococcal pneumonia (PP), legionella pneumonia (LP), and mycoplasma pneumonia (MP).
• To identify potential distinguishing characteristics that could aid in the early diagnosis of these common pneumonia types.

Main Methods:

• Retrospective analysis of 83 cases of PP, 79 cases of LP, and 62 cases of MP.
• Comparison of clinical presentation, laboratory findings, and patient demographics.
• Statistical analysis to identify significant differences between the groups.

Main Results:

• No single unique feature definitively identified any of the three groups.
• Mycoplasma pneumonia (MP) patients were younger, had more upper respiratory symptoms, and fewer systemic signs compared to PP and LP.
• Multisystem involvement was common in PP and LP, with LP more frequently associated with confusion, high fever, hyponatremia, and liver function abnormalities.
• High leukocyte counts were particularly noted in PP.

Conclusions:

• Clinical and laboratory features alone are insufficient for definitive etiological diagnosis of CAP.
• Mycoplasma pneumonia (MP) exhibits a distinct clinical profile compared to pneumococcal pneumonia (PP) and legionella pneumonia (LP).
• Empirical antibiotic therapy for CAP remains necessary until microbiological diagnosis is confirmed.